CELLINK has entered into an agreement to acquire the Biodispensing company Dispendix GmbH CELLINK AB (“CELLINK”) has entered into an agreement with the owner of Dispendix GmbH. (“Dispendix”) to acquire all shares in Dispendix for a purchase amount of 5 M €(“Acquisition”). “Our innovative products for non-contact, high throughput dispensing and CELLINK ́s comprehensive bioprinting

To read the full story...

Already a subscriber? Login now

< | >